UK to start trials to test effectiveness of convalescent plasma treatment on coronavirus patients

Britain is set to start trials to see whether plasma from coronavirus survivors could help in the recovery of those who have been severely affected with the COVID-19 disease. According to a statement on Saturday from British health department, up to 5,000 severely ill patients with COVID-19 could soon be treated each week with plasma…

COVID-19 patients respond positively to Gilead Sciences experimental drug

Shares of Gilead Sciences Inc’s shares jumped by 16% following news reports that its experimental drug remdesivir is proving to be effective in U.S. trials of patients who have been severely afflicted by the COVID-19 disease caused by the coronavirus. According to a report from medical news website STAT, a University of Chicago hospital participating…

SpaceX bans Zoom video conferencing app citing significant security threats

SpaceX, Elon Musk’s rocket company, has banned its employees from using Zoom, a video conferencing app, following “significant privacy and security concerns”, according to an internal memo. The development comes days after U.S. law enforcement agencies warned users about security concerns regarding the popular app. With many Americans quarrantined in their homes because of the…

GE & Ford to produce 50,000 ventilators in 100 days starting from April 20

In a statement, Ford Motor Co said it will produce 50,000 ventilators over the next 100 days from its plant in Michigan in collaboration with General Electric’s healthcare unit. Following this, it can build 30,000 ventilators per month so as to treat patients afflicted with China’s Wuhan coronavirus. The simplified ventilator design, licensed by GE…